Search

Search Constraints

You searched for: Author/Creator Ahmed, Zeshan

Search Results

1. [IC‐P‐024]: INVESTIGATING GLYMPHATIC FUNCTION DURING EARLY TAU PATHOLOGY USING DYNAMIC CONTRAST‐ENHANCED MRI. (1st July 2017)

2. [O2–14–04]: AGGREGATE‐SELECTIVE ANTI‐TAU ANTIBODY MC‐1 DEMONSTRATED ROBUST IN VITRO AND IN VIVO ACTIVITY TO NEUTRALIZE TRANSMISSIBLE TAU AND REDUCE TAU PATHOLOGY. (1st July 2017)

3. [O3–04–02]: DEVELOPING IN VIVO MODELS OF TAU PROPAGATION WHICH ARE RELEVANT TO HUMAN DISEASE PATHOGENESIS AND APPLICABLE TO PRE‐CLINICAL DRUG DISCOVERY. (1st July 2017)

4. [P1–144]: TRANSCRIPTIONAL AND EPIGENOMIC PROFILING IN THE ENTORHINAL CORTEX IN AMYLOID AND TAU MOUSE MODELS OF ALZHEIMER's DISEASE. (1st July 2017)

5. [P1–354]: INVESTIGATING GLYMPHATIC FUNCTION DURING EARLY TAU PATHOLOGY USING DYNAMIC CONTRAST‐ENHANCED MRI. (1st July 2017)

6. [P3–178]: IN VIVO TWO‐PHOTON IMAGING OF THE EFFECTS OF TAUOPATHY AND AMYLOIDOPATHY ON SYNAPSES. (1st July 2017)

7. Characterization of mRNA isoform diversity in a transgenic model of tau pathology using targeted long‐read sequencing: Genetics/molecular genetics. (7th December 2020)

8. Genome‐wide DNA methylation signatures of tau and amyloid neuropathology: Genetics: Genetics of cognitive aging, other dementia, and endophenotypes. (7th December 2020)

9. Global shifts in DNA methylation and DNA hydroxymethylation across multiple brain regions in transgenic models of tau and amyloid pathology: Molecular and cell biology/others. (7th December 2020)

10. IC‐P‐019: DYNAMIC CONTRAST‐ENHANCED MRI TO ASSESS GLYMPHATIC FUNCTION IN THE NL‐F MOUSE MODEL OF ALZHEIMER'S DISEASE. (1st July 2019)